Black Diamond Therapeutics Inc. (BDTX): Price and Financial Metrics
BDTX Price/Volume Stats
| Current price | $2.35 | 52-week high | $6.75 |
| Prev. close | $2.46 | 52-week low | $1.20 |
| Day low | $2.34 | Volume | 6,072,200 |
| Day high | $2.55 | Avg. volume | 2,289,067 |
| 50-day MA | $2.03 | Dividend yield | N/A |
| 200-day MA | $2.51 | Market Cap | 133.63M |
BDTX Stock Price Chart Interactive Chart >
Black Diamond Therapeutics Inc. (BDTX) Company Bio
Black Diamond Therapeutics, Inc. engages in the biotechnology company that discovers and develops therapeutic agents to target unique oncogenic protein-isoforms. The company was founded by Dr. David M. Epstein and Dr. Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.
BDTX Price Returns
| 1-mo | 6.82% |
| 3-mo | 51.61% |
| 6-mo | 9.81% |
| 1-year | -49.57% |
| 3-year | -4.47% |
| 5-year | -94.43% |
| YTD | 9.81% |
| 2024 | -23.84% |
| 2023 | 56.11% |
| 2022 | -66.23% |
| 2021 | -83.37% |
| 2020 | N/A |
Loading social stream, please wait...